| FZAFX | GFACX | FZAFX / GFACX | |
| Total Expense Ratio | 0.55 | 1.36 | 40% |
| Annual Report Gross Expense Ratio | 0.55 | 1.36 | 40% |
| Fund Existence | 12 years | 25 years | - |
| Gain YTD | 12.626 | 14.445 | 87% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 13.1B | 330B | 4% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | 3.72 | 5.07 | 73% |
| Returns for 3 years | 71.32 | 54.86 | 130% |
| Returns for 5 years | 40.25 | 24.08 | 167% |
| Returns for 10 years | 150.75 | 69.66 | 216% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| RSPF | 73.52 | 0.13 | +0.17% |
| Invesco S&P 500® Equal Weight Fincl ETF | |||
| DEED | 21.59 | 0.03 | +0.14% |
| First Trust Securitized Plus ETF | |||
| VIOV | 92.37 | -0.18 | -0.19% |
| Vanguard S&P Small-Cap 600 Value ETF | |||
| TEC | 27.30 | -0.31 | -1.12% |
| Harbor Transformative Technologies ETF | |||
| BIS | 9.94 | -0.13 | -1.29% |
| ProShares UltraShort Nasdaq Biotech | |||